Description: Eucrates Biomedical Acquisition Corp. focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was founded in 2020 and is based in New York, New York.
250 West 55th Street
New York,
NY
10019
United States
Phone:
212 710 5220
Officers
| Name | Title |
|---|---|
| Mr. Parag Phoolchand Saxena MBA, MS | CEO & Director |
| Dr. Evangelos Vergetis | Pres, COO & Director |
| Mr. Gonzalo Cordova CFA | Chief Financial Officer |
| Mr. Shrikant Sathe | Sr. VP |
Exchange: NASDAQ
Country: US
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 52.6316 |
| Price-to-Book MRQ: | 0.4124 |
| Price-to-Sales TTM: | 0 |
| IPO Date: | 2020-12-29 |
| Fiscal Year End: | December |
| Full Time Employees: | 0 |